(₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 411.36 | 428.73 | 344.57 | -4.1% | 19.4% |
Total Expenses | 317.02 | 323.38 | 259.80 | -2.0% | 22.0% |
Profit Before Tax | 94.33 | 105.35 | 84.76 | -10.5% | 11.3% |
Tax | 25.39 | 26.35 | 22.19 | -3.6% | 14.4% |
Profit After Tax | 68.94 | 79.01 | 62.57 | -12.7% | 10.2% |
Earnings Per Share | 6.80 | 7.80 | 6.10 | -12.8% | 11.5% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Rainbow Children's Medicare Ltd is a prominent player in the pediatric healthcare sector. The company specializes in providing medical care and services primarily focused on pediatric and maternal healthcare. Rainbow Children's Medicare operates a network of hospitals and clinics that cater to a wide range of healthcare needs for children and mothers, including neonatal care, pediatric intensive care, and specialized surgeries. As a leader in its field, Rainbow Children's has been at the forefront of delivering comprehensive health services aimed at improving child health outcomes. There are no recent major developments specified in the provided data.
For the third quarter of the fiscal year 2025 (Q3FY25), Rainbow Children's Medicare Ltd reported a total income of ₹411.36 crores. This marks a decrease of 4.1% when compared to the previous quarter (Q2FY25), where the total income was ₹428.73 crores. However, on a year-over-year basis, the total income increased by 19.4% from ₹344.57 crores in Q3FY24. The quarterly fluctuations and annual growth in total income reflect changes in revenue generation, which may be influenced by various factors, including market demand and service offerings.
The profitability of Rainbow Children's Medicare Ltd for Q3FY25 is highlighted by a Profit Before Tax (PBT) of ₹94.33 crores, which is a decrease of 10.5% from the ₹105.35 crores reported in Q2FY25. When compared to the same quarter in the previous fiscal year (Q3FY24), where the PBT was ₹84.76 crores, there is an increase of 11.3%. After accounting for taxes, the Profit After Tax (PAT) for Q3FY25 stands at ₹68.94 crores, down 12.7% from ₹79.01 crores in Q2FY25, yet up by 10.2% from ₹62.57 crores in Q3FY24. The Earnings Per Share (EPS) for Q3FY25 is ₹6.80, reflecting a decline of 12.8% from Q2FY25, but an increase of 11.5% from Q3FY24.
The total expenses for Rainbow Children's Medicare Ltd in Q3FY25 amounted to ₹317.02 crores, showing a 2.0% decrease from the previous quarter's total expenses of ₹323.38 crores. Year-over-year, there is a 22.0% increase from ₹259.80 crores in Q3FY24. The tax expense for Q3FY25 was ₹25.39 crores, which is a 3.6% decrease from ₹26.35 crores in Q2FY25 and a 14.4% increase from ₹22.19 crores in Q3FY24. These metrics provide insights into the company's cost management and tax liabilities over the periods in question.